Skip to main content
. 2019 Feb 6;10(2):535–547. doi: 10.1007/s13300-019-0578-6

Table 10.

Different stage comparison of hypoglycemic episodes before and after ABM-MNC therapy

Items (months) Test for heterogeneity Analysis model Test for overall effect WMD or SMD 95% CI
I2 (%) P Z P
3 0 0.34 Fixed 3.70 < 0.001 6.40 (3.01, 9.79)
6 0 0.96 Fixed 0.30 0.76 − 0.30 (− 2.25, 1.65)
12 7 0.30 Fixed 0.75 0.45 − 1.00 (− 3.61, 1.62)